Antigen-specific suppressor T-ceil hybridomas release soluble suppressor factors (TsF) in the supernatant that modulate both in vivo delayed-type hypersensitivity and in vitro plaque-forming cell responses in an antigen-specific manner.
The T-cell antigen receptors (TcR) on helper and cytotoxic T cells are CD3-associated a/P3 heterodimers. Initially, donorderived TcR (3-chain rearrangements were not detected in antigen-specific suppressor T-cell (Ts) hybridomas (1, 2) . Subsequent analyses of Ts hybridomas indicated that Ts do express TcR a-chain mRNA derived from the Ts donor (3, 4) and that some express the CD3-TcR a/(3 complex on their surface (5) (6) (7) (8) (9) (10) (11) . Selection of Ts hybridomas for expression of surface CD3 resulted in an increase in antigen binding (11) and suppressive bioactivity (11, 12) . Molecular analysis of three 4-hydroxy-3-nitrophenyl acetyl (NP)-specific suppressor effector (Ts3) hybridomas indicated that each expressed a donor-derived TcR a chain and a TcR (3 chain derived from the BW5147 fusion partner (4) . The absence of a full-length (3-chain transcript and the presence of TcR a-chain determinants on the suppressor factor (TsF) from one of these lines suggested that the TcR (3 chain was not necessary for Ts function and that the TcR a chain might form part of the TsF (4). Data from several independent antigen-specific suppressor systems support this conclusion (9, 10, 13, 14) . Here we examine the effects of loss of TcR a-and (3-chain expression on TsF bioactivity and use cDNA transfection to demonstrate that TcR a chain is required for Ts function.
MATERIALS AND METHODS Animals. Mice were purchased from The Jackson Laboratory or were bred at Harvard Medical School.
Antigen. NP-O-succinimide (NP-O-Su) was purchased from Lynx Technologies (San Rafael, CA), p-azobenzenearsonate (ABA), trimethylammonia (TMA), and hapten conjugates were provided by S. Jayaraman.
Antibodies. Hamster anti-CD3 antibody (145-2C11) and anti-Ly6C (144-4B11) were obtained from J. Bluestone (University of Chicago). The anti-TcR a (H28.710) and anti-TcR , (H57.597) hybridomas were a gift from R. Kubo (10) . We generated expression variants from these hybridomas following the method of antigen-or antibody-mediated growth inhibition (10 (19) . Stable transfectants were selected in G418 (1.5 mg/ml) (GIBCO). Five clones were obtained after transfection with CKB-Ts1-38 TcR a cDNA, three of which showed suppressor activity in bioassays. Clones 38al and 38a5 were selected for further functional analysis. After transfection with BW5147 TcR a cDNA, eight clones grew out. Clone BWa5 was used as a control since it expressed the highest percentage (2%) of CD3-TcR-bearing cells.
Affinity Absorption of TsF. TsF-containing supernatants were adsorbed by batch methods and eluted with 2 M KCI as described (4, 20) .
Suppression of Delayed-Type Hypersensitivity (DTH) Responses. Mice were immunized with 200,g ofNP-O-Su or 200 ,ul of 10 mM ABA (diazonium salt) as described (10) . To assay for suppressive bioactivity, mice were injected i.v. with 0.5 ml of conditioned medium on days 0 and 1 after antigen priming. On day 6, mice were challenged in the left footpad with the appropriate hapten and footpad swelling responses were measured by caliper 24 hr later.
Suppression of Plaque-Forming Cell (PFC) Responses. TsF1 activity was assayed as described (21) . Briefly, naive C57BL/6 or B10.BR responder spleen cells were immunized in vitro with NP-coupled horse or uncoupled sheep erythrocytes. Conditioned media from Ts were added on day 0 at final dilutions of 1:20 or 1:200. Direct anti-NP or anti-sheep erythrocyte PFCs were detected on day 5 by using a modified Jerne plaque assay (21) . All DTH and PFC assays were conducted independently at separate institutions.
RESULTS

Generation of Expression Variants and Transfectants. We
recently derived a series of NP-specific Ts, hybridomas that share phenotypic properties (Thyl+, CD3+, CD4+, CD8-, Ig-, Macl-) with the Ts1 cell populations that mediate inducer-phase suppression in cell transfer experiments (10, 22) . Among this group of 14 NP-specific, CD4+ hybridomas with donor-derived TcR a/,B chains, 3 constitutively released TsF and specifically responded to antigen in the presence of H-2 (IE)-compatible APCs (10) . These Ts hybridomas may be related to the IE-or DQ-restricted Ts clones reported in other murine and human systems (6, 23 2 ). In contrast, the TcR a-(A38.3.G7) and TcR -(A38.4.D2) expression variants failed to stain with these reagents. Transfection of A38.3.G7 with the CKB-Ts1-38-derived TcR a cDNA reconstituted surface expression of the CD3-TcR complex in line 38a5 (Fig. 2) . Transfectant 38al and BWa5, however, showed little or no detectable CD3-TcR complex on their surface by flow cytometry, although each contained transcripts of the transfected cDNA (data not shown).
To evaluate whether the TcRs transduced antigen-specific signals, we compared growth inhibition of the parental, expression variant, and transfected cell lines with antigen (NP-KLH) or anti-TcR antibodies. The parental and transfected (38a5) cell lines were growth inhibited upon stimulation with either specific antigen (NP-KLH), anti-CD3, antiTcR-C1, or anti-V,96 antibodies (Table 1 expression variants and transfectants were tested for suppressive bioactivity. Supernatant containing TsF from the parental CKB-Ts1-38 hybridoma suppresses NP responses in both DTH and PFC assays ( Table 2 ). The suppressor activity was antigen specific since DTH responses to the control hapten ABA and PFC responses to control antigen (sheep erythrocyte) were not affected. Three different TcR aexpression variants derived from line CKB-Tsl-38 were tested and all lost suppressive activity (Table 2) , whereas both TcR P-expression variants that retain expression of TcR a mRNA (A38.4.C2 and -.D2) produced antigen-specific TsF activity. In addition, another TcR a'(3 expression variant (A81.4.F8) from a second NP-specific Ts hybridoma (CKB-Ts1-81) also produced antigen-specific TsF activity. Expression variant A81.3.Ell lost expression of both TcR chains (data not shown) and also lost the ability to produce TsF. Thus, the loss of TcR a expression correlated with lack of suppressive bioactivity ( Table 2) .
To prove that the TcR a chain plays a role in antigenspecific suppressor cell function, the ability of TcR a transfectants to produce antigen-specific suppressor activity was examined. Both homologous TcR a transfectants (38al and 38a5) specifically suppressed DTH and PFC responses to NP ( share serological determinants with TcR a chain and bind antigen in the absence of TcR (3-chain expression.
DISCUSSION
We have examined the role of TcR a and , chains in antigen recognition and antigen-specific suppressor cell function. Utilizing the strategies of TcR a or p expression loss variants followed by reconstitution with homologous TcR a cDNA, a critical role for TcR a chain in antigen-specific Ts function was directly demonstrated. (11) . This observation has been confirmed in other suppressor T-cell systems (12, 24, 25) . Recently, a series of Ts hybridomas was prepared by fusion with the TcR a-73-BW1100 thymoma; all Ts, hybridomas from this fusion express Ts donor-derived TcR a/,8 complexes (10). Thus, data from our and other laboratories using different antigen systems (5, 6, 8, 9, 25) in contrast to the findings of Fairchild et al. (13, 24) , who reported that a TsF released by a 2,4-dinitrophenyl-specific hybridoma shares serological determinants with both TcR a and ( chains. The factors studied by Fairchild et al. (13, 24) have other distinguishing features; i.e., they are produced by CD8+-derived cells and display class I restriction, which is presumably determined by TcR P chain (24) . In contrast, the NP-specific factors described here are derived from CD4' cells and lack H-2 restriction. The current data demonstrate that antigen-specific TsF activity from all three TcR a+f-mutants can be absorbed by an anti-TcR a (but not anti-TcR *)-chain-specific antibody (Table 3) , supporting the concept that TcR a chain forms part of the antigen-specific TsF molecule. This is consistent with the observations made in other suppressor systems in which it has been shown that antisense oligonucleotides to TcR a (but not TcR /3 chain) block production of a component of suppressor factor (14) and that suppressor activity can be absorbed by anti-TcR-Ca antibody (4, 9, 10, 13, 24, 25) . The shared antigen specificity ofthe cell surface TcR a/.B and TsF implies that the TcR a chain alone is sufficient for antigen binding by TsF. These assumptions are supported by data from other hapten systems in which TcR a chains are involved in antigen recognition (24, 26) .
Previous studies demonstrated that TsF is targeted to APCs, and that TsF-pulsed APCs induce a second population of Ts (Ts2) with antiidiotypic specificity (22) . It has been difficult to envision the mechanism by which antiidiotypic specificity could be achieved if the specificity was directed to a conformational determinant on a heterodimeric TcR a/(3, since each protein chain is processed separately. The current studies imply that in the NP system only the TcR a chain is involved in network regulation; thus, APC processing of a single chain is consistent with the idiotypic specificity observed. Such a mechanism may also account for the network regulation noted in other systems (27) .
It is not clear at this stage how the TcR a chain is released from Ts. The cDNA expressed in the transfectants contains a C region that is identical in sequence to that of the published cell-surface TcR a chain (data not shown; see ref. 28 for C, sequence). Thus, alternative splicing of the TcR a does not appear to be required for TsF production. Furthermore, it is unclear whether the TsF is released from viable cells or the 1-7% dead cells present when the TsF-containing supernatants are harvested. Data obtained from COS cell transfection models suggest that unless the TcR a chain is stabilized by other components of the CD3-TcR complex, the TcR a chain will be rapidly degraded or trapped in the endoplasmic reticulum (29, 30 Evidence from multiple Ts systems suggests that TsF molecule may be a heterodimer (22, 25, 31) . If the TcR a chain controls antigen specificity, the postulated second chain could mediate bioactivity. Recent studies with TcR ( chain transgenic mice have provided evidence for a chain that complexes with TcR (3 chain in the absence of CD3 and the TcR a, thus demonstrating that other TcR-associated proteins remain to be characterized (32) .
In summary, the critical role of TcR a chain in Ts antigen recognition and TsF function has been directly demonstrated. Loss of TcR a, but not TcR (, RNA results in loss of suppressor bioactivity, which can be specifically restored by transfection with homologous TcR a cDNA. Further analysis of the TcR a chain, its mechanism of release, and its potential association with alternative chains may help us understand the mechanism by which this molecule mediates suppressor function.
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